These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 22168319)

  • 1. Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin?
    Carlet J; Mainardi JL
    Clin Microbiol Infect; 2012 Jan; 18(1):1-3. PubMed ID: 22168319
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro evaluation of antibiotic synergy for NDM-1-producing Enterobacteriaceae.
    Berçot B; Poirel L; Dortet L; Nordmann P
    J Antimicrob Chemother; 2011 Oct; 66(10):2295-7. PubMed ID: 21807739
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of colistin or sulbactam in combination with fosfomycin or imipenem against clinical isolates of carbapenem-resistant Acinetobacter baumannii producing OXA-23 carbapenemases.
    Santimaleeworagun W; Wongpoowarak P; Chayakul P; Pattharachayakul S; Tansakul P; Garey KW
    Southeast Asian J Trop Med Public Health; 2011 Jul; 42(4):890-900. PubMed ID: 22299471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High frequency of co-resistance in CTX-M-producing Escherichia coli to non-beta-lactam antibiotics, with the exceptions of amikacin, nitrofurantoin, colistin, tigecycline, and fosfomycin, in a county of Sweden.
    Östholm Balkhed Å; Tärnberg M; Monstein HJ; Hällgren A; Hanberger H; Nilsson LE
    Scand J Infect Dis; 2013 Apr; 45(4):271-8. PubMed ID: 23113731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Increasing prevalence of fosfomycin resistance in extended-spectrum-beta-lactamase-producing Escherichia coli urinary isolates (2005-2009-2011)].
    Rodríguez-Avial C; Rodríguez-Avial I; Hernández E; Picazo JJ
    Rev Esp Quimioter; 2013 Mar; 26(1):43-6. PubMed ID: 23546462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains.
    Evren E; Azap OK; Çolakoğlu Ş; Arslan H
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):335-8. PubMed ID: 23726147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of critically ill intensive care unit patients treated with fosfomycin for infections due to pandrug-resistant and extensively drug-resistant carbapenemase-producing Gram-negative bacteria.
    Pontikis K; Karaiskos I; Bastani S; Dimopoulos G; Kalogirou M; Katsiari M; Oikonomou A; Poulakou G; Roilides E; Giamarellou H
    Int J Antimicrob Agents; 2014 Jan; 43(1):52-9. PubMed ID: 24183799
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro susceptibility pattern of cephalosporin-resistant Gram-negative bacteria.
    Punpanich W; Tantichattanon W; Wongwatcharapaiboon S; Treeratweeraphong V
    J Med Assoc Thai; 2008 Oct; 91 Suppl 3():S21-7. PubMed ID: 19255989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antibacterial activity of co-trimoxazole and tetroxoprim/sulfadiazine in vitro (author's transl)].
    Hahn H; Kirov A
    Arzneimittelforschung; 1980; 30(7):1047-8. PubMed ID: 7191284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrons, β-lactamase and qnr genes in multidrug resistant clinical isolates of Proteus mirabilis and P. vulgaris.
    Mokracka J; Gruszczyńska B; Kaznowski A
    APMIS; 2012 Dec; 120(12):950-8. PubMed ID: 23030307
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antimicrobial susceptibility of multidrug-resistant (MDR) and extensively drug-resistant (XDR) Enterobacteriaceae isolates to fosfomycin.
    Falagas ME; Maraki S; Karageorgopoulos DE; Kastoris AC; Mavromanolakis E; Samonis G
    Int J Antimicrob Agents; 2010 Mar; 35(3):240-3. PubMed ID: 20034765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activity and penetration of fosfomycin, ciprofloxacin, amoxicillin/clavulanic acid and co-trimoxazole in Escherichia coli and Pseudomonas aeruginosa biofilms.
    Rodríguez-Martínez JM; Ballesta S; Pascual A
    Int J Antimicrob Agents; 2007 Oct; 30(4):366-8. PubMed ID: 17616359
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of pH on activity of trimethoprim, fosfomycin, amikacin, colistin and ertapenem in human urine.
    Burian A; Erdogan Z; Jandrisits C; Zeitlinger M
    Pharmacology; 2012; 90(5-6):281-7. PubMed ID: 23037005
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relative potency of different generic brands of meropenem, colistin and fosfomycin: Implications for antimicrobial therapy and antimicrobial formulary.
    Das P; Jana B; Dhar K; Goel G; Bhattacharya S; Chandy M
    Indian J Med Microbiol; 2019; 37(1):95-98. PubMed ID: 31424016
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Panresistance in VIM-1-producing Klebsiella pneumoniae.
    Miriagou V; Tzelepi E; Daikos GL; Tassios PT; Tzouvelekis LS
    J Antimicrob Chemother; 2005 May; 55(5):810-1. PubMed ID: 15772141
    [No Abstract]   [Full Text] [Related]  

  • 16. Extended-spectrum beta-lactamase-producing and carbapenemase-producing Enterobacter cloacae ventriculitis successfully treated with intraventricular colistin.
    Cascio A; Mezzatesta ML; Odierna A; Di Bernardo F; Barberi G; Iaria C; Stefani S; Giordano S
    Int J Infect Dis; 2014 Mar; 20():66-7. PubMed ID: 24412601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial resistance of Listeria monocytogenes.
    Poroś-Głuchowska J; Markiewicz Z
    Acta Microbiol Pol; 2003; 52(2):113-29. PubMed ID: 14594399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro activity of the combination trimethoprim plus sulfamethoxazole compared with that of other chemotherapeutic agents.
    Focht J; Klietmann W; Nösner K
    Arzneimittelforschung; 1988 Aug; 38(8):1085-8. PubMed ID: 3264166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Infectious diseases caused by carbapenemase-producing Enterobacteriaceae--a particular challenge for antibacterial therapy].
    Stock I
    Med Monatsschr Pharm; 2014 May; 37(5):162-72; quiz 173-4. PubMed ID: 24908928
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Colistin/daptomycin: an unconventional antimicrobial combination synergistic in vitro against multidrug-resistant Acinetobacter baumannii.
    Galani I; Orlandou K; Moraitou H; Petrikkos G; Souli M
    Int J Antimicrob Agents; 2014 Apr; 43(4):370-4. PubMed ID: 24560919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.